Researchers from Taiwan report the identification of a new form of drug-resistant salmonella bacterium in this week’s issue of THE LANCET.
Salmonella enterica serotype choleraesuis usually causes infections that require antimicrobial treatment. Multidrug-resistant strains have been identified, but the antimicrobial ceftriaxone has been effective against them so far.
Professor J T Ou, from Chang Gung University College of Medicine, Taoyuan, Taiwan, and colleagues isolated a strain of Salmonella enterica serotype choleraesuis that was resistant to all antimicrobials commonly used to treat salmonellosis, including ceftriaxone and ciprofloxacin. The bacterium came from a 58-year-old man with sepsis who subsequently died.
The drug-resistance was due to changes in the genes of the bacteria, including some in a genetic element that can potentially be transmitted between bacteria. Although this strain was from only one patient, the public-health implications of multidrug-resistant salmonella are serious. “Constant surveillance is needed to prevent its further spread,” warn the authors.
Contact:
Prof J T Ou, Department of Microbiology and Immunology, Chang Gung University College of Medicine, 259 Wenhua 1st Road, Kweishan 333, Taoyuan, Taiwan. Fone: +886 3 2118800; Fax: +886 3 2118455; Email: jontou@mail.cgu.edu.tw
Richard Lane | Source: alphagalileo
More articles from
Life Sciences:
Hope for Alzheimer’s Patients?
04.12.2008 | Angewandte Chemie International Edition
New "Control Knobs" for Stem Cells Identified
04.12.2008 | Tufts University
New solutions enhancing road safety developed in Finland
04.12.2008 | Transportation and Logistics
Why is the Earth’s mantle conductive?
04.12.2008 | Earth Sciences
ESA satellites flying in formation
04.12.2008 | Physics and Astronomy
Dublin to host Europe’s largest interdisciplinary science conference in 2012
28.11.2008 | Event News
28.11.2008 | Event News
The Automobile – The Transition from Energy Guzzler to Power Supplier
20.11.2008 | Event News